ALINT.PA
Price:
$0.6099
Market Cap:
$4.04M
IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to ...[Read more]
Industry
Biotechnology
IPO Date
2010-06-18
Stock Exchange
EURONEXT
Ticker
ALINT.PA
According to IntegraGen SA’s latest financial reports and current stock price. The company's current PE Ratio is -15.25. This represents a change of 852.21% compared to the average of -1.60 of the last 4 quarters.
The mean historical PE Ratio of IntegraGen SA over the last ten years is -196.99. The current -15.25 PE Ratio has changed 674.16% with respect to the historical average. Over the past ten years (40 quarters), ALINT.PA's PE Ratio was at its highest in in the June 2020 quarter at 154.17. The PE Ratio was at its lowest in in the December 2014 quarter at -22.48.
Average
-196.99
Median
-16.91
Minimum
-2286.81
Maximum
475.99
Discovering the peaks and valleys of IntegraGen SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 265.16%
Maximum Annual PE Ratio = 475.99
Minimum Annual Increase = -1410.17%
Minimum Annual PE Ratio = -2286.81
Year | PE Ratio | Change |
---|---|---|
2024 | -14.87 | -56.90% |
2023 | -34.49 | -98.49% |
2022 | -2286.81 | -580.43% |
2021 | 475.99 | -1410.17% |
2020 | -36.33 | 58.02% |
2019 | -22.99 | 265.16% |
2018 | -6.30 | -66.77% |
2017 | -18.95 | 83.80% |
2016 | -10.31 | -30.43% |
2015 | -14.82 | -41.54% |
The current PE Ratio of IntegraGen SA (ALINT.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-778.73
5-year avg
-379.30
10-year avg
-196.99
IntegraGen SA’s PE Ratio is less than Hybrigenics SA (-0.21), greater than Theradiag SA (-33.61), less than Adocia SA (-8.14), less than Sensorion SA (-4.80), less than Poxel S.A. (-0.94),
Company | PE Ratio | Market cap |
---|---|---|
-0.21 | $3.95M | |
-33.61 | $17.29M | |
-8.14 | $88.57M | |
-4.80 | $125.99M | |
-0.94 | $18.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IntegraGen SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IntegraGen SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is IntegraGen SA's PE Ratio?
How is the PE Ratio calculated for IntegraGen SA (ALINT.PA)?
What is the highest PE Ratio for IntegraGen SA (ALINT.PA)?
What is the 3-year average PE Ratio for IntegraGen SA (ALINT.PA)?
What is the 5-year average PE Ratio for IntegraGen SA (ALINT.PA)?
How does the current PE Ratio for IntegraGen SA (ALINT.PA) compare to its historical average?